Citations

Showing 10 of 108162 citations.

Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease
Rinaldo, Lorenzo , Brinjikji, Waleed , Huston, John , Klaas, James P. , Lehman, Vance T. , Cogswell, Petrice M. , Lanzino, Giuseppe

Mayo Clinic

Neurosurgical Focus | December 6, 2019 | Volume: 47 | Issue: 6 | Pages: E6

10.3171/2019.9.focus19616 | PMID 31786551 Get It

Numerous recent technological advances offer the potential to substantially enhance the MRI evaluation of moyamoya disease (MMD). These include high-resolution volumetric imaging, high-resolution vessel wall characterization, improved cerebral angiographic and perfusion techniques, high-field imaging, fast scanning methods, and artificial intelligence. This review discusses the current state-of-the-art MRI applications in these realms, emphasizing key imaging findings, clinical utility, and areas that will benefit from further investigation. Although these techniques may apply to imaging of a wide array of neurovascular or other neurological conditions, consideration of their application to MMD is useful given the comprehensive multidimensional MRI assessment used to evaluate MMD. These MRI techniques span from basic cross-sectional to advanced functional sequences, both qualitative and quantitative. The aim of this review was to provide a comprehensive summary and analysis of current key relevant literature of advanced MRI techniques for the evaluation of MMD with image-rich case examples. These imaging methods can aid clinical characterization, help direct treatment, assist in the evaluation of treatment response, and potentially improve the understanding of the pathophysiology of MMD.
Intravascular Large B-cell Lymphoma Associated with Systemic and Central Nervous System Hemophagocytic Lymphohistiocytosis: A Case Report
Verma, Aradhana, Sharma, Akanksha , Robetorye, Ryan S. , Porter, Alyx B. , Robetorye, Ryan, Porter, Alyx, Hilal, Talal

Mayo Clinic

The Permanente Journal | December 6, 2019 | Volume: 24 | Issue: 1 | Pages: No page available

10.7812/tpp/19.105 | PMID 31852057 Get It

Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
Moyer, Ann M. , Matey, Eric T. , Miller, Virginia M.

Mayo Clinic

Pharmacology Research & Perspectives | December 6, 2019 | Volume: 7 | Issue: 6 | Pages: No page available

10.1002/prp2.541 | PMID 31844524 Get It

AbstractClinically relevant adverse drug reactions differ between men and women. The underlying physiological and pharmacological processes contributing to these differences are infrequently studied or reported. As gene expression, cellular regulatory pathways, and integrated physiological functions differ between females and males, aggregating data from combined groups of men and women obscures the ability to detect these differences. This paper summarizes how genetic sex, that is, the presence of sex chromosomes XY for male or XX for female, and the influence of sex hormones affect transporters, receptors, and enzymes involved in drug metabolism. Changing levels of sex steroids throughout life, including increases at puberty, changes with pregnancy, and decreases with age, may directly and indirectly affect drug absorption, distribution, metabolism, and elimination. The direct and indirect effects of sex steroids in the form of exogenous hormones such as those used in hormonal contraceptives, menopausal hormone treatments, transgender therapy, and over‐the‐counter performance enhancing drugs may interfere with metabolism of other pharmaceuticals, and these interactions may vary by dose, formulation, and mode of delivery (oral, injection, or transdermal) of the steroid hormones. Few drugs have sex‐specific labeling or dosing recommendations. Furthermore, there is limited literature evaluating how the circulating levels of sex steroids impact drug efficacy or adverse reactions. Such research is needed in order to improve the understanding of the impact of sex hormones on pharmacological therapies, particularly as medicine moves toward individualizing treatments.
A Rare Case of Eosinophilic Esophagitis and Dysphagia Lusoria
Koop, Andree , Francis, Dawn L.

Mayo Clinic

American Journal of Gastroenterology | December 6, 2019 | Volume: 115 | Issue: 7 | Pages: 975-975

10.14309/ajg.0000000000000475 | PMID 32618641 Get It

Vacuum-Assisted Subcision for Gluteal Contouring
Carr, Emily, Hoss, Elika, Kollipara, Ramya, Fabi, Sabrina G.

Mayo Clinic

Dermatologic Surgery | December 6, 2019 | Volume: 47 | Issue: 2 | Pages: 294-296

10.1097/dss.0000000000002274 | PMID 31809352 Get It

Internal Medicine Resident Professionalism Assessments: Exploring the Association With Patients’ Overall Satisfaction With Their Hospital Stay
Ratelle, John T. , Halvorsen, Andrew J. , Mandrekar, Jay , Sawatsky, Adam P. , Reed, Darcy A. , Beckman, Thomas J.

Mayo Clinic

Academic Medicine | December 6, 2019 | Volume: 95 | Issue: 6 | Pages: 902-910

10.1097/acm.0000000000003114 | PMID 31809293 Get It

Purpose Successful training of internal medicine (IM) residents requires accurate assessments. Patients could assess IM residents in a hospital setting, but medical educators must understand how contextual factors may affect assessments. The objective was to investigate relationships between patient, resident, and hospital-encounter characteristics and the results of patient assessments of IM resident professionalism. Method The authors performed a prospective cohort study of postgraduate year 1 (PGY-1) IM residents and their patients at 4 general medicine inpatient teaching services at Mayo Clinic Hospital–Rochester, Saint Marys Campus in Rochester, Minnesota, from July 1, 2015, through June 30, 2016. Patient assessments of resident professionalism were adapted from validated instruments. Multivariable modeling with generalized estimating equations was used to determine associations between patient assessment scores and characteristics of residents, residents’ clinical performance and evaluations (including professionalism assessments in other settings), patients, and hospital encounters and to account for repeated assessments of residents. Results A total of 409 patients assessed 72 PGY-1 residents (mean [SD], 5.7 [3.0] patient assessments per resident). In the multivariable model, only the highest rating out of 5 levels for overall satisfaction with hospital stay was significantly associated with patient assessment scores of resident professionalism (β [SE], 0.80 [0.08]; P < .001). Hospitalized patients’ assessment scores of resident professionalism were not significantly correlated with assessment scores of resident professionalism in other clinical settings. Conclusions Hospitalized patients’ assessment scores of in-hospital resident professionalism were strongly correlated with overall patient satisfaction with hospital stay but were not correlated with resident professionalism in other settings. The limitations of patient evaluations should be considered before incorporating these evaluations into programs of assessment.
Molecular Imaging of Stem Cells
Gambhir, Sanjiv S. , Rodriguez‐Porcel, Martin , Abbas, Fakhar, Wu, Joseph C.

Mayo Clinic

StemJournal | December 6, 2019 | Volume: 1 | Issue: 1 | Pages: 27-46

10.3233/stj-190003 Get It

Regenerative medicine with the use of stem cells has appeared as a potential therapeutic alternative for many disease states. Despite initial enthusiasm, there has been relatively slow transition to clinical trials. In large part, numerous questions remain regarding the viability, biology and efficacy of transplanted stem cells in the living subject. The critical issues highlighted the importance of developing tools to assess these questions. Advances in molecular biology and imaging have allowed the successful non-invasive monitoring of transplanted stem cells in the living subject. Over the years these methodologies have been updated to assess not only the viability but also the biology of transplanted stem cells. In this review, different imaging strategies to study the viability and biology of transplanted stem cells are presented. Use of these strategies will be critical as the different regenerative therapies are being tested for clinical use.
Cochrane Sustainable Healthcare: evidence for action on too much medicine
Johansson, Minna , Bonfill, Xavier , Bruschettini, Matteo , Garner, Sarah , Glenton, Claire , Harris, Russell, Jørgensen, Karsten Juhl , Levinson, Wendy , Lotfi, Tamara , Meng, Dina Muscat, Schünemann, Holger J. , Woloshin, Steven , Moynihan, Ray , Schünemann, Holger J , Lotfi, Tamara , Bero, Lisa Anne , Montori, Víctor M. , Carneiro, António Vaz

Mayo Clinic

Cochrane Database of Systematic Reviews | December 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/14651858.ed000143 | PMID 31808554 Get It

Maturation of Lipophagic Organelles in Hepatocytes Is Dependent Upon a Rab10/Dynamin‐2 Complex
Li, Zhipeng , Weller, Shaun G. , Drizyte‐Miller, Kristina , Chen, Jing , Krueger, Eugene W. , Mehall, Bridget, Stöckli, Jacqueline, Cao, Hong , McNiven, Mark A. , Drizyte-Miller, Kristina , Crossman, Bridget E. , Casey, Carol A.

Mayo Clinic

Hepatology | December 6, 2019 | Volume: 72 | Issue: 2 | Pages: 486-502

10.1002/hep.31059 | PMID 31808574 Get It

Background and Aims Hepatocytes play a central role in storage and utilization of fat by the liver. Selective breakdown of lipid droplets (LDs) by autophagy (also called lipophagy) is a key process utilized to catabolize these lipids as an energy source. How the autophagic machinery is selectively targeted to LDs, where it mediates membrane engulfment and subsequent degradation, is unclear. Recently, we have reported that two distinct GTPases, the mechanoenzyme, dynamin2 (Dyn2), and the small regulatory Rab GTPase, Rab10, work independently at distinct steps of lipophagy in hepatocytes. Approach and Results In an attempt to understand how these proteins are regulated and recruited to autophagic organelles, we performed a nonbiased biochemical screen for Dyn2‐binding partners and found that Dyn2 actually binds Rab10 directly through a defined effector domain of Rab10 and the middle domain of Dyn2. These two GTPases can be observed to interact transiently on membrane tubules in hepatoma cells and along LD‐centric autophagic membranes. Most important, we found that a targeted disruption of this interaction leads to an inability of cells to trim tubulated cytoplasmic membranes, some of which extend from lipophagic organelles, resulting in LD accumulation. Conclusions This study identifies a functional, and direct, interaction between Dyn2 and a regulatory Rab GTPase that may play an important role in hepatocellular metabolism.
Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea
Camilleri, Michael , Chey, William D. , Shaffer, Eldon A., Tse, Frances , Sadowski, Daniel C , Leontiadis, Grigorios I. , Marshall, John K. , Walters, Julian R.F.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | December 6, 2019 | Volume: 3 | Issue: 1 | Pages: e10-e27

10.1093/jcag/gwz038 | PMID 32010878 Get It

Abstract Background and Aims Chronic diarrhea affects about 5% of the population overall. Altered bile acid metabolism is a common but frequently undiagnosed cause. Methods We performed a systematic search of publication databases for studies of assessment and management of bile acid diarrhea (BAD). The certainty (quality) of evidence and strength of recommendations were rated according to the Grading of Recommendation Assessment, Development and Evaluation approach. Patient population, intervention, comparator and outcome questions were developed through an iterative process and were voted on by a group of specialists. Results The certainty of evidence was generally rated as very low. Therefore, 16 of 17 recommendations are conditional. In patients with chronic diarrhea, consideration of risk factors (terminal ileal resection, cholecystectomy or abdominal radiotherapy), but not additional symptoms, was recommended for identification of patients with possible BAD. The group suggested testing using 75selenium homocholic acid taurine (where available) or 7α-hydroxy-4-cholesten-3-one, including patients with irritable bowel syndrome with diarrhea, functional diarrhea and Crohn’s disease without inflammation. Testing was suggested over empiric bile acid sequestrant therapy (BAST). Once remediable causes are managed, the group suggested cholestyramine as initial therapy, with alternate BAST when tolerability is an issue. The group suggested against BAST for patients with extensive ileal Crohn’s disease or resection and suggested alternative antidiarrheal agents if BAST is not tolerated. Maintenance BAST should be given at the lowest effective dose, with a trial of intermittent, on-demand administration, concurrent medication review and reinvestigation for patients whose symptoms persist despite BAST. Conclusions Based on a systematic review, BAD should be considered for patients with chronic diarrhea. For patients with positive results from tests for BAD, a trial of BAST, initially with cholestyramine, is suggested.